Health News

New Drug for Kids With Crohn's
Treatments that do exist for Crohn's disease (CD) don't always work for everyone, kids included. But a new remedy helping adults with their stomach issues may work for children. Is it safe for the little ones?
AS Medication Didn't Change Heart Risks
A long term disease named  Ankylosing   Spondylitis has been linked to a higher risk of cardiovascular problems. A number of factors could be responsible for this increased risk, including the drugs used to treat this painful condition.
Upping the Dose in Crohn's Treatments
Easing the discomfort with Crohn's disease remains a difficult task. Though the troubles could be swayed with two medicines, the effects are temporary.
New Drug for Crohn's Patients
Maybe this is the end of long-term stomach aches and pains, at least for patients with Crohn's disease who don't respond to the common treatment.
To Switch or Not To Switch AS Drugs
No two patients with ankylosing spondylitis are exactly the same. As such, a drug treatment that works for one patient may not work for the other. When one drug isn't working out, patients may turn to another drug.
RA Drugs Carry Similar Risk
Many experts recommend that rheumatoid arthritis patients get early drug treatment to slow down their disease and prevent disability. With so many drug options, it's important to know the safety of each drug.
No Doubt About Arthritis Drug's Benefit
A few years ago, the FDA warned that certain drugs may raise the risk of cancer in children with juvenile arthritis. While it still seems these children are more prone to cancer, the drugs might not be to blame.
The RA Heart Left Unprotected
The inflammation of rheumatoid arthritis can affect more than the joints; it also poses a threat to the heart. When it comes to protecting the heart health of rheumatoid arthritis patients, certain drugs are falling short.
FDA Focus on TNF Blockers
A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.
Psoriasis Drugs Not Linked to Cardiovascular Problems
Early reports indicating drugs treating psoriasis were linked to major cardiovascular events seem to lack evidence.